Devices and methods for protecting against neuromas
The subject invention provides devices and methods for alleviating discomfort associated with neuroma formation. The devices and methods of the invention effectively use the body's natural response of reconstructing implanted biomaterials to minimize the size of isolate, and protect a neuroma. In preferred embodiments, the subject device is a cylindrical cap, wherein the internal chamber of the cylindrical cap physically partitions the nerve to enable an arrangement of nerve fibers (as opposed to haphazardly arranged nerve fibers often produced in neuromas). Tabs arranged on the outside of the cap can be used to manipulate the cap into place on a nerve. The open end can also be configured with flaps that can be used to widen the open end for easier insertion of the nerve into the cap. In addition, the cap's material remodels into a tissue cushion after implantation, which protects the neuroma from being stimulated and inducing pain.
1. A device comprising:
a body having an open proximal end and a closed distal end, wherein the open proximal end is the only opening in the body; and
an internal chamber defined by the body, wherein the internal chamber is physically partitioned,
wherein the body of the device is about 1 mm to about 500 mm in length.
2. The device of claim 1 , further comprising a biomaterial configured to remodel into a tissue cushion after implantation of the device.
3. The device of claim 1 , wherein the body of the device is about 1 mm to about 100 mm in diameter.
4. The device of claim 1 , wherein the body of the device is about 1 mm to about 100 mm in length.
5. The device of claim 4 , wherein the body of the device is about 1 mm to about 25 mm in diameter.
6. The device of claim 1 , wherein the body has a diameter at a distal end region that is less than a diameter at a proximal end region.
7. The device of claim 1 , wherein the body has a diameter at a distal end region that is approximately equal to a diameter at a proximal end region.
8. The device of claim 1 , wherein an interior surface of the closed distal end is beveled, conical, or flat.
9. The device of claim 1 , wherein the device comprises a biomaterial selected from the group consisting of: high-density polyethylene (HDPE), polyethylene glycol (PEG) hydrogel, purified protein from human or animal sources, and decellularized tissue constructs.
10. The device of claim 9 , wherein the biomaterial is selected from the group consisting of: collagen, fibrin, demineralized bone, amnion, small intestine submucosa (SIS), dermis, or fascia.
11. The device of claim 9 , wherein the device comprises porous HDPE or PEG surrounded by a layer of non-porous HDPE or PEG.
12. The device of claim 1 , wherein the body is cylindrical in shape.
13. A method of using the device of claim 1 , comprising inserting a nerve stump into the proximal end of the device.
14. The method of claim 13 , wherein a neuroma formed out of the inserted nerve stump is protected from external stimuli.
15. The method of claim 13 , wherein nerve outgrowth that forms from the inserted nerve stump is separated within the internal chamber of the device after implantation of the device.
16. A method for preventing or limiting neuroma formation, the method comprising inserting and securing a nerve stump into the device of claim 1 .
17. The method of claim 16 , wherein the nerve stump is secured into the device using one or more of a suture, a staple, a clip, or a surgical adhesive or sealant.
18. The method of claim 16 , wherein neuroma formation is limited as compared to neuroma formation without the device.
19. A method comprising:
inserting and securing a nerve stump into the device of claim 1 to decrease pain associated with a neuroma formation as compared to pain associated with a neuroma formation without the device.
20. The method of claim 19 , wherein the nerve stump is secured into the device using one or more of a suture, a staple, a clip, or a surgical adhesive or sealant.